Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Morbidity and mortality after allogeneic hematopoietic cell transplantation (alloHCT) are still essentially affected by reactivation of cytomegalovirus (CMV). We evaluated 80 seropositive patients transplanted consecutively between March 2018 and March 2019 who received letermovir (LET) prophylaxis...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Hematol
Huvudupphovsmän: Derigs, Patrick, Radujkovic, Aleksandar, Schubert, Maria-Luisa, Schnitzler, Paul, Schöning, Tilman, Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O., Luft, Thomas, Dreger, Peter, Schmitt, Michael
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285358/
https://ncbi.nlm.nih.gov/pubmed/33270162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04362-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk